e-learning
resources
Virtual 2021
06.09.2021
Management of chronic cough and obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The use of objective 24 hour cough monitoring to measure clinical improvement in cystic fibrosis.
K. Brindle (Hull, United Kingdom), R. Thompson (Hull, United Kingdom), C. Wright (Hull, United Kingdom), T. Cavany (Hull, United Kingdom), D. Ingram (Hull, United Kingdom), M. Robinson (Hull, United Kingdom), A. Morice (Hull, United Kingdom)
Source:
Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Session:
Management of chronic cough and obstructive diseases
Session type:
E-poster
Number:
1940
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Brindle (Hull, United Kingdom), R. Thompson (Hull, United Kingdom), C. Wright (Hull, United Kingdom), T. Cavany (Hull, United Kingdom), D. Ingram (Hull, United Kingdom), M. Robinson (Hull, United Kingdom), A. Morice (Hull, United Kingdom). The use of objective 24 hour cough monitoring to measure clinical improvement in cystic fibrosis.. 1940
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
Cystic fibrosis and intestinal organoids
Related content which might interest you:
Is impulse oscillometry (IOS) better than spirometry for monitoring treatment outcomes in adult cystic fibrosis (CF) pulmonary exacerbations? A pilot study
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
The value of lung function monitoring by means of a home monitor in patients with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Year: 2011
Feasibility study of an intervention to increase treatment adherence in children with cystic fibrosis (CF)
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019
Usefulness of web transmission of overnight recording of SaO2 and daily FEV1 in the early diagnosis of pulmonary exacerbations in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 529s
Year: 2002
The concept of cystic fibrosis pulmonary exacerbation in clinical medicine and as a trial end-point
Source: Annual Congress 2008 - Exacerbations of chronic respiratory disease – state of the art
Year: 2008
An increase in steps per day 6 weeks after pulmonary rehabilitation of COPD patients correlates with an improvement in quality of life
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020
Change in functional lung MRI and multiple breath washout outcomes over one year in children with cystic fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021
Denufosol targets small airways and elicits meaningful improvements in mild cystic fibrosis (CF) patients on minimal pharmacotherapy
Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections
Year: 2010
The effect of spirometry on multiple breath washout outcomes in children with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
6 and 12 month outcomes following RePneu bronchoscopic lung volume reduction coil treatment
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
18
FDG-PET imaging detects inflammatory changes in pediatric cystic fibrosis patients after treatment for a pulmonary exacerbation
Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections
Year: 2010
COPD: problems in diagnosis and measurement
Source: Eur Respir J 2003; 21: 4S-12S
Year: 2003
Analysis of the daily symptom profile of patients with non-cystic fibrosis bronchiectasis (NCFB) using a symptom diary.
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Should use of 4 hours continuous positive airway pressure per night be considered acceptable compliance?
Source: Eur Respir J 2014; 44: 1119-1120
Year: 2014
A simple assessment of dyspnea as a prognostic indicator in idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010
Variability of the lung clearance index (LCI) assessed pre and post physiotherapy in patients with cystic fibrosis (CF)
Source: Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology
Year: 2008
Comparison of exercise capacity, physical activity level and quality of life in patients with different severity of non-cystic fibrosis bronchiectasis>
Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease
Year: 2021
24 hour
versus
early morning spontaneous sputum collection for routine microbiology in stable bronchiectasis
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
CFTR biomarkers: time for promotion to surrogate end-point
Source: Eur Respir J 2013; 41: 203-216
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept